
Academic Journal
Q2Acta Neuropsychiatrica
About Acta Neuropsychiatrica
Acta Neuropsychiatrica is a scholarly journal published by Cambridge University Press. SCImago 2025 lists it in Q2, with an SJR of 0.677 and H-index of 49.
Coverage: 1989-2004, 2006-2026. Research categories: Psychiatry and Mental Health (Q2); Biological Psychiatry (Q3).
Source-backed journal facts
Topics in published research
Schizophrenia research and treatment; Tryptophan and brain disorders; Bipolar Disorder and Treatment; Treatment of Major Depression; Neurotransmitter Receptor Influence on Behavior; Stress Responses and Cortisol.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
3,550.00 USD; 2,460.00 GBP
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Comparative Clinical and Cognitive Outcomes of rTMS and Vortioxetine in Major Depressive Disorder
Onur Durmaz, Ekin Sönmez Güngör, Sibel Çakıtlı
2026-08-10 · DOI: 10.1017/neu.2026.10092Investigation of leptin and leptin receptor gene polymorphisms in schizophrenia: further support for an association with attempted suicide
Hasan Mervan AYTAC, Yasemin OYACI, Eren AYTAC, Mustafa PEHLIVAN et al.
2026-02-10 · DOI: 10.1017/neu.2026.10058The effects of alpha-pinene on anxiety behaviours and TLR4/MYD88/NF-kB pathway in the hippocampus in the reserpine-induced anxiety model in rats
Matin Nasiri, Kaveh Rahimi, Zohreh Ghotbeddin
2026 · DOI: 10.1017/neu.2026.10080Predicting the need for electroconvulsive therapy via machine learning trained on electronic health record data
Lasse Hansen, Jakob Grøhn Damgaard, Robert M. Lundin, Andreas Aalkjær Danielsen et al.
2026 · DOI: 10.1017/neu.2026.10063Bilateral DLPFC transcranial direct current stimulation for mood and motor symptoms in Parkinson’s disease: a preliminary study
Boram Chae, Jae-Ha Song, Do-Young Kwon, Ho-Kyoung Yoon et al.
2026 · DOI: 10.1017/neu.2026.10082The effects of psychedelics on attention-deficit and hyperactivity disorder – a systematic review
Helerin Raikkerus, Andrea Bujor, Mark Kennedy, Jari Tiihonen et al.
2026 · DOI: 10.1017/neu.2026.10088Psilocybin elicits a conserved glucocorticoid-responsive gene signature across five 5-HT2A receptor-rich brain regions in rat
Ashkan Veysi, Daniela Atanasovski, Maryam Ardalan, Nasrin Motamed et al.
2026 · DOI: 10.1017/neu.2026.10075Differences in verbal memory, visuospatial ability and cognitive inhibition among young women using drospirenone and ethinyl oestradiol oral contraceptives versus naturally cycling controls
Natalia Lagunas, Laura Sánchez-Giraldo, Daniela Grassi, Teresa Diéguez-Risco et al.
2026 · DOI: 10.1017/neu.2025.10053Peripheral metabolic–redox signaling as a core mechanism of major depressive disorder: evidence from deep metabolomic phenotyping
Michael Maes, Mengqi Niu, Annabel Maes, Yiping Luo et al.
2026 · DOI: 10.1017/neu.2026.10065Aspirin and atorvastatin augmentation treatment in patients with major affective disorders and inflammatory dysregulation: a 12-week randomised Placebo-controlled study
Ya-Mei Bai, Ju-Wei Hsu, Ying-Jay Liou, Mu-Hong Chen et al.
2026 · DOI: 10.1017/neu.2025.10050Sleep state is superior to resting state for heart rate variability assessment in major depressive disorder
Shurui Chen, Minfeng Cheng, Xi Fang, Zhibin Tang et al.
2026 · DOI: 10.1017/neu.2026.10064Music and binaural beat interventions for young adults: A systematic review of effects on anxiety, sleep, and cognition
Hesham Yousry Elnazer
2026 · DOI: 10.1017/neu.2026.10057A comprehensive systematic review of human trials investigating herbal treatments for Alzheimer’s disease and dementia
Katarzyna Aleksandra Kaczmarek-Kryszak, Małgorzata Dobrzyńska, Michalina Banaszak, Sławomira Drzymała-Czyż et al.
2026 · DOI: 10.1017/neu.2026.10085Early-life adversity induces metabolic alterations in a rodent model of depression: a differential stress response perspective
Daniël J. van Rensburg, Zander Lindeque, Ashleigh Jade Whitney, Stephan F. Steyn et al.
2026 · DOI: 10.1017/neu.2026.10066When artificial intelligence speaks: psychologically adverse effects of the shift from text- to voice-based chatbots
Marc Augustin, Søren Dinesen Østergaard
2026 · DOI: 10.1017/neu.2026.10062Effects of electroconvulsive therapy on oxidative stress in schizophrenia
Yağmur Darben Azarsız, Ezgi Sıla Ahi Üstün, Hasan Kaya, Pınar Dumancı et al.
2026 · DOI: 10.1017/neu.2026.10095Parenteral clomipramine for depression or obsessive-compulsive disorder: a systematic review and meta-analysis
Michael Ioannou, Örjan Falk, Joss Gustavsson, Johan Nilsson et al.
2026 · DOI: 10.1017/neu.2026.10074Electroconvulsive therapy during the COVID-19 pandemic: nationwide data from Denmark
Christian Jon Reinecke-Tellefsen, Anders Ørberg, Søren Dinesen Østergaard
2026 · DOI: 10.1017/neu.2026.10068Neurorestorative properties of ibogaine: linking multi-receptor affinities to remyelination and metabolic restoration
Tanya Calvey, Demi Govender, Gavin R. Owen, Nancy Tumba et al.
2026 · DOI: 10.1017/neu.2026.10059Heroin assessment in Spanish population-based studies: a scoping review
Ana Teijeiro, Ana García-González, Nerea Mourino, Sara Correia et al.
2026 · DOI: 10.1017/neu.2026.10081Reviews
Community Reviews
Version History
October 4, 2026 at 9:09 pm
October 2, 2026